BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20164056)

  • 1. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
    Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
    Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
    Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
    Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor.
    Wangsiricharoen S; Ingram DR; Morey RR; Wani K; Lazar AJ; Wang WL
    Mod Pathol; 2024 Mar; 37(3):100426. PubMed ID: 38219952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A central role for regulated protein stability in the control of TFE3 and MITF by nutrients.
    Nardone C; Palanski BA; Scott DC; Timms RT; Barber KW; Gu X; Mao A; Leng Y; Watson EV; Schulman BA; Cole PA; Elledge SJ
    Mol Cell; 2023 Jan; 83(1):57-73.e9. PubMed ID: 36608670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.
    Testa S; Bui NQ; Ganjoo KN
    Cancer Res Commun; 2023 Jul; 3(7):1212-1223. PubMed ID: 37448552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary malignant PEComa with TFE3 rearrangement in foot bones: A case report.
    Lei S; Fang X; Zhang W; Duan H
    Asian J Surg; 2024 Apr; 47(4):1837-1838. PubMed ID: 38143179
    [No Abstract]   [Full Text] [Related]  

  • 7. ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.
    Sicinska E; Kola VSR; Kerfoot JA; Taddei ML; Al-Ibraheemi A; Hsieh YH; Church AJ; Landesman-Bollag E; Landesman Y; Hemming ML
    Cancer Res; 2024 Apr; ():. PubMed ID: 38657118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFE3 promotes ferroptosis in melanoma.
    Dias D; Louphrasitthiphol P; Goding CR
    Pigment Cell Melanoma Res; 2024 Mar; 37(2):286-290. PubMed ID: 37953065
    [No Abstract]   [Full Text] [Related]  

  • 9. TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.
    Schoolmeester JK; Dao LN; Sukov WR; Wang L; Park KJ; Murali R; Hameed MR; Soslow RA
    Am J Surg Pathol; 2015 Mar; 39(3):394-404. PubMed ID: 25517951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
    Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
    Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kim NI; Lee JS; Choi YD; Ju UC; Nam JH
    World J Clin Cases; 2020 Sep; 8(18):4207-4214. PubMed ID: 33024780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of 18 perivascular epithelioid cell tumor cases.
    Jia R; Jiang L; Zhou Y; Wang Y; Guo X; Ji Y; Ni X; Yang X
    Medicine (Baltimore); 2020 Aug; 99(34):e21659. PubMed ID: 32846779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanotic Xp11-associated tumor of the sigmoid colon: A case report.
    Wang G; Li GG; Zhu SM; Cai BJ; Yu PJ; Zhang CW
    World J Clin Cases; 2019 Mar; 7(5):684-690. PubMed ID: 30863770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway.
    Fang Y; Bao W; Rao Q; Wang X; Xia Q; Shen Q; Zhou X; Yao B
    Mol Med Rep; 2017 Sep; 16(3):2721-2725. PubMed ID: 28713889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
    Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
    Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin K in the immunohistochemical diagnosis of melanocytic lesions.
    Rao Q; Wang Y; Xia QY; Shi SS; Shen Q; Tu P; Shi QL; Zhou XJ; Wu B
    Int J Clin Exp Pathol; 2014; 7(3):1132-9. PubMed ID: 24696729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFE3 expression in tumors of the microphthalmia-associated transcription factor (MiTF) family.
    Dickson BC; Brooks JS; Pasha TL; Zhang PJ
    Int J Surg Pathol; 2011 Feb; 19(1):26-30. PubMed ID: 20164056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
    Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
    Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.